Ibrutinib plus CIT for R/R mature B-NHL in children (SPARKLE trial): initial safety, pharmacokinetics, and efficacy

G. A.Amos Burke; Auke Beishuizen; Deepa Bhojwani; Birgit Burkhardt; Véronique Minard-Colin; Robin E. Norris; Edita Kabickova; F. Guclu Pinarli; Nurdan Tacyildiz; Angela Howes; Jan de Jong; Grace Liu; Kerri Nottage; Mariya Salman; Xavier Woot de Trixhe; Mitchell Cairo

doi:10.1038/s41375-020-0749-5

Ibrutinib plus CIT for R/R mature B-NHL in children (SPARKLE trial): initial safety, pharmacokinetics, and efficacy

G. A.Amos Burke^*, Auke Beishuizen, Deepa Bhojwani, Birgit Burkhardt, Véronique Minard-Colin, Robin E. Norris, Edita Kabickova, F. Guclu Pinarli, Nurdan Tacyildiz, Angela Howes, Jan de Jong, Grace Liu, Kerri Nottage, Mariya Salman, Xavier Woot de Trixhe, Mitchell Cairo

^*Corresponding author for this work

Cancer and Genomic Sciences

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	2271-2275
Number of pages	5
Journal	Leukemia
Volume	34
Issue number	8
DOIs	https://doi.org/10.1038/s41375-020-0749-5
Publication status	Published - 1 Aug 2020

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/s41375-020-0749-5

Cite this

Burke, G. A. A., Beishuizen, A., Bhojwani, D., Burkhardt, B., Minard-Colin, V., Norris, R. E., Kabickova, E., Pinarli, F. G., Tacyildiz, N., Howes, A., Jong, J. D., Liu, G., Nottage, K., Salman, M., Trixhe, X. W. D., & Cairo, M. (2020). Ibrutinib plus CIT for R/R mature B-NHL in children (SPARKLE trial): initial safety, pharmacokinetics, and efficacy. Leukemia, 34(8), 2271-2275. https://doi.org/10.1038/s41375-020-0749-5

@article{741a05d9dbe944a7b219e6a58bd25455,

title = "Ibrutinib plus CIT for R/R mature B-NHL in children (SPARKLE trial): initial safety, pharmacokinetics, and efficacy",

author = "Burke, \{G. A.Amos\} and Auke Beishuizen and Deepa Bhojwani and Birgit Burkhardt and V{\'e}ronique Minard-Colin and Norris, \{Robin E.\} and Edita Kabickova and Pinarli, \{F. Guclu\} and Nurdan Tacyildiz and Angela Howes and Jong, \{Jan de\} and Grace Liu and Kerri Nottage and Mariya Salman and Trixhe, \{Xavier Woot de\} and Mitchell Cairo",

year = "2020",

month = aug,

day = "1",

doi = "10.1038/s41375-020-0749-5",

language = "English",

volume = "34",

pages = "2271--2275",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "8",

}

Burke, GAA, Beishuizen, A, Bhojwani, D, Burkhardt, B, Minard-Colin, V, Norris, RE, Kabickova, E, Pinarli, FG, Tacyildiz, N, Howes, A, Jong, JD, Liu, G, Nottage, K, Salman, M, Trixhe, XWD & Cairo, M 2020, 'Ibrutinib plus CIT for R/R mature B-NHL in children (SPARKLE trial): initial safety, pharmacokinetics, and efficacy', Leukemia, vol. 34, no. 8, pp. 2271-2275. https://doi.org/10.1038/s41375-020-0749-5

TY - JOUR

T1 - Ibrutinib plus CIT for R/R mature B-NHL in children (SPARKLE trial)

T2 - initial safety, pharmacokinetics, and efficacy

AU - Burke, G. A.Amos

AU - Beishuizen, Auke

AU - Bhojwani, Deepa

AU - Burkhardt, Birgit

AU - Minard-Colin, Véronique

AU - Norris, Robin E.

AU - Kabickova, Edita

AU - Pinarli, F. Guclu

AU - Tacyildiz, Nurdan

AU - Howes, Angela

AU - Jong, Jan de

AU - Liu, Grace

AU - Nottage, Kerri

AU - Salman, Mariya

AU - Trixhe, Xavier Woot de

AU - Cairo, Mitchell

PY - 2020/8/1

Y1 - 2020/8/1

UR - http://www.scopus.com/inward/record.url?scp=85079822301&partnerID=8YFLogxK

U2 - 10.1038/s41375-020-0749-5

DO - 10.1038/s41375-020-0749-5

M3 - Letter

C2 - 32071430

AN - SCOPUS:85079822301

SN - 0887-6924

VL - 34

SP - 2271

EP - 2275

JO - Leukemia

JF - Leukemia

IS - 8

ER -